Jean Grem

Trials

Studies that name Jean Grem as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 22:58 UTC. Open this list on ClinicalTrials.gov

• Ph2
  NCT04141995 · FOLFIRINOX With Digoxin in Patients With Resectable Pancreatic Cancer

  University of Nebraska · terminated · Pancreas Cancer, Adenocarcinoma of the Pancreas · principal investigator
• Ph1
  NCT01206465 · Pralatrexate and Fluorouracil in Treating Patients With Recurrent Solid Tumors

  University of Nebraska · completed · Unspecified Adult Solid Tumor, Protocol Specific · principal investigator
• Ph1
  NCT00019708 · Geldanamycin Analogue in Treating Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma

  National Cancer Institute (NCI) · terminated · Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue, Nodal Marginal Zone B-cell Lymphoma, Non-Hodgkin Lymphoma · principal investigator

Grants

NIH projects from RePORTER, fetched 2026-11-11 22:58 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 1 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.

NIH grants that fund their trials

These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.

• Developmental Research Program
  P50CA127297 · NCI · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI Michael A. Hollingsworth · fiscal years 2008 to 2018
  Named on NCT04141995